Details
Stereochemistry | ACHIRAL |
Molecular Formula | C20H10Br4O10S2 |
Molecular Weight | 794.033 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1=CC=C(C=C1S(O)(=O)=O)C2(OC(=O)C3=C(Br)C(Br)=C(Br)C(Br)=C23)C4=CC(=C(O)C=C4)S(O)(=O)=O
InChI
InChIKey=OHTXTCNTQJFRIG-UHFFFAOYSA-N
InChI=1S/C20H10Br4O10S2/c21-15-13-14(16(22)18(24)17(15)23)20(34-19(13)27,7-1-3-9(25)11(5-7)35(28,29)30)8-2-4-10(26)12(6-8)36(31,32)33/h1-6,25-26H,(H,28,29,30)(H,31,32,33)
Molecular Formula | C20H10Br4O10S2 |
Molecular Weight | 794.033 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Sulfobromophthalein (BSP) is a dye with a high affinity for organic anion transporting polypeptides (OATPs) and has been used as a substrate for multidrug resistance associated protein 2 (Mrp2). BSP is transported into hepatocytes by OATPs and, after conjugation to glutathione, is excreted into bile by Mrp2.3 It was found to inhibit the aldo-keto reductase ARK1C20. Sulfobromophthalein (BSP) is used in diagnosis of hepatic disorders.It is also used for the quantitative determination of proteins.
Originator
Sources: https://www.ncbi.nlm.nih.gov/pubmed/14192521
Curator's Comment: Sulfobromophthalein sodium (BSP, Bromsulphalein) has been used extensively for testing hepatic function since its introduction by Rosenthal and White in 1925
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL1697668 |
44.0 nM [Ki] | ||
Target ID: glutathione S-transferase, Oesophagostomum dentatum |
|||
Target ID: CHEMBL2073676 Sources: https://www.ncbi.nlm.nih.gov/pubmed/15618649 |
2.18 µM [Ki] | ||
Target ID: 116852.0 Gene Symbol: Akr1c20 Sources: https://www.ncbi.nlm.nih.gov/pubmed/16508162 |
1.0 µM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Diagnostic | Bromosulfoftaleina Sodium Approved UseDiagnostic aid in hepatic function determination |
PubMed
Title | Date | PubMed |
---|---|---|
Biliary excretion of flavopiridol and its glucuronides in the isolated perfused rat liver: role of multidrug resistance protein 2 (Mrp2). | 2003 Oct 17 |
|
Involvement of Mrp2 (Abcc2) in biliary excretion of moxifloxacin and its metabolites in the isolated perfused rat liver. | 2008 Jan |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15618649
Rats: 350mg/day, i.v.
Route of Administration:
Intravenous
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6019914
In competitive binding studies in vitro between
Sulfobromophthalein (BSP) and a series of organic anions
(sodium fluorescein, indocyanine green, bilirubin,
sodium taurocholate, flavaspidic acid
glucaminate, and iodipamide methylglucamine),
the incubation mixture contained 500 ug of BSP and equimolar amounts of the
aforementional organic anions. On the average,
160 +/- 2 ug BSP was bound per mg of membrane
protein and 1.4 +/-0.1 ug BSP bound
per unit of Co++-CMPase activity in 15
membrane isolates. BSP binding
was maximal at 500 ug BSP/ml in the
incubation mix with proportionately less binding
observed at lower concentrations. BSP
concentrations above 500 ug/ml reduced BSP
binding and produced dissolution of cell membranes.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:43:53 GMT 2023
by
admin
on
Fri Dec 15 16:43:53 GMT 2023
|
Record UNII |
0C2P5QKL36
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
V04CE02
Created by
admin on Fri Dec 15 16:43:53 GMT 2023 , Edited by admin on Fri Dec 15 16:43:53 GMT 2023
|
||
|
WHO-VATC |
QV04CE02
Created by
admin on Fri Dec 15 16:43:53 GMT 2023 , Edited by admin on Fri Dec 15 16:43:53 GMT 2023
|
||
|
NCI_THESAURUS |
C461
Created by
admin on Fri Dec 15 16:43:53 GMT 2023 , Edited by admin on Fri Dec 15 16:43:53 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C87724
Created by
admin on Fri Dec 15 16:43:53 GMT 2023 , Edited by admin on Fri Dec 15 16:43:53 GMT 2023
|
PRIMARY | |||
|
0C2P5QKL36
Created by
admin on Fri Dec 15 16:43:53 GMT 2023 , Edited by admin on Fri Dec 15 16:43:53 GMT 2023
|
PRIMARY | |||
|
100000077544
Created by
admin on Fri Dec 15 16:43:53 GMT 2023 , Edited by admin on Fri Dec 15 16:43:53 GMT 2023
|
PRIMARY | |||
|
63836
Created by
admin on Fri Dec 15 16:43:53 GMT 2023 , Edited by admin on Fri Dec 15 16:43:53 GMT 2023
|
PRIMARY | |||
|
DB13215
Created by
admin on Fri Dec 15 16:43:53 GMT 2023 , Edited by admin on Fri Dec 15 16:43:53 GMT 2023
|
PRIMARY | |||
|
10212
Created by
admin on Fri Dec 15 16:43:53 GMT 2023 , Edited by admin on Fri Dec 15 16:43:53 GMT 2023
|
PRIMARY | RxNorm | ||
|
206-047-5
Created by
admin on Fri Dec 15 16:43:53 GMT 2023 , Edited by admin on Fri Dec 15 16:43:53 GMT 2023
|
PRIMARY | |||
|
2531
Created by
admin on Fri Dec 15 16:43:53 GMT 2023 , Edited by admin on Fri Dec 15 16:43:53 GMT 2023
|
PRIMARY | |||
|
D013448
Created by
admin on Fri Dec 15 16:43:53 GMT 2023 , Edited by admin on Fri Dec 15 16:43:53 GMT 2023
|
PRIMARY | |||
|
SUB15430MIG
Created by
admin on Fri Dec 15 16:43:53 GMT 2023 , Edited by admin on Fri Dec 15 16:43:53 GMT 2023
|
PRIMARY | |||
|
DTXSID4075378
Created by
admin on Fri Dec 15 16:43:53 GMT 2023 , Edited by admin on Fri Dec 15 16:43:53 GMT 2023
|
PRIMARY | |||
|
5345
Created by
admin on Fri Dec 15 16:43:53 GMT 2023 , Edited by admin on Fri Dec 15 16:43:53 GMT 2023
|
PRIMARY | |||
|
297-83-6
Created by
admin on Fri Dec 15 16:43:53 GMT 2023 , Edited by admin on Fri Dec 15 16:43:53 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |